BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

15 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Imidazole and triazole containing bicyclic compounds as JAK inhibitorsBDB
Theravance Biopharma R&D Ip
1-cyano-pyrrolidine compounds as USP30 inhibitorsBDB
Mission Therapeutics
CXCR7 antagonistsBDB
Chemocentryx
Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivativeBDB
Institute of Materia Medica, Chinese Academy of Medical Sciences
Carboxamide derivatives useful as rsk inhibitorsBDB
Phoenix Molecular Designs
Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomasBDB
Department Of Health and Human Services
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereofBDB
Guangzhou Maxinovel Pharmaceuticals
Pyrrolo[2,3-d]pyrimidine compound or salt thereofBDB
Taiho Pharmaceutical
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseBDB
Lycera
Protein kinase C inhibitors and methods of their useBDB
Novartis
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.BDB
Abbvie
Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.BDB
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylaseBDB
Albert Einstein College of Medicine
Trk-inhibiting compoundBDB
Ono Pharmaceutical
Inhibition of memapsin 1 cleavage in the treatment of diabetesBDB
Oklahoma Medical Research Foundation